Needham & Company Reiterates a 'Buy' on Vertex (VRTX); Combination Trial in CF Encouraging

Go back to Needham & Company Reiterates a 'Buy' on Vertex (VRTX); Combination Trial in CF Encouraging
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Delayed: 505.75 --0 (-0%)
Previous Close $505.75    52 Week High $134.71 
Open $505.75    52 Week Low $73.31 
Day High $505.75    P/E N/A 
Day Low $505.75    EPS $-1.98 
Volume 1,373